| TITLE |
DATE |
| ACADIA Pharmaceuticals to Present at the Oppenheimer 22nd Annual Healthcare Conference on December 14, 2011 |
7-Dec-2011 |
| ACADIA Pharmaceuticals Reports Third Quarter 2011 Financial Results |
9-Nov-2011 |
| ACADIA Pharmaceuticals Advances AM-831 to Phase I Clinical Development in Collaboration with Meiji Seika Pharma |
7-Nov-2011 |
| ACADIA Pharmaceuticals to Announce Third Quarter 2011 Financial Results on November 9, 2011 |
2-Nov-2011 |
| ACADIA Pharmaceuticals to Present at the Sixth Annual JMP Securities
Healthcare Conference on September 28, 2011 |
21-Sep-2011 |
| ACADIA Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference on September 12, 2011 |
6-Sep-2011 |
| ACADIA Pharmaceuticals Reports Second Quarter 2011 Financial Results |
10-Aug-2011 |
| ACADIA Pharmaceuticals to Announce Second Quarter 2011 Financial Results on August 10, 2011 |
3-Aug-2011 |
| ACADIA Pharmaceuticals Awarded Grant from National Institutes of Health for the Development of Novel ER-beta Agonists |
17-May-2011 |
| ACADIA Pharmaceuticals Reports First Quarter 2011 Financial Results |
10-May-2011 |
| ACADIA Pharmaceuticals to Present at the Tenth Annual JMP Securities Research Conference on May 11, 2011 |
4-May-2011 |
| ACADIA Pharmaceuticals to Announce First Quarter 2011 Financial Results on May 10, 2011 |
3-May-2011 |
| ACADIA Pharmaceuticals Announces Extension of Drug Discovery Collaboration with Allergan, Inc. |
1-Apr-2011 |
| ACADIA Pharmaceuticals to Present at the Tenth Annual Needham Healthcare Conference on April 5, 2011 |
29-Mar-2011 |
| ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2010 |
10-Mar-2011 |
| ACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year 2010 Financial Results on March 10, 2011 |
3-Mar-2011 |
| ACADIA Pharmaceuticals to Present at the Thirteenth Annual BIO CEO & Investor Conference on February 15, 2011 |
8-Feb-2011 |
| ACADIA Pharmaceuticals Announces $15 Million Private Placement |
10-Jan-2011 |
| ACADIA Pharmaceuticals Reports Third Quarter 2010 Financial Results |
9-Nov-2010 |
| ACADIA Pharmaceuticals Awarded Grant from The Michael J. Fox Foundation for the Development of Novel Nurr1-RXR Agonists to Treat Parkinson's Disease |
9-Nov-2010 |
| ACADIA Pharmaceuticals to Announce Third Quarter 2010 Financial Results on November 9, 2010 |
2-Nov-2010 |
| ACADIA Pharmaceuticals Enters Agreement with Biovail to Conclude Collaboration and Regain North American Rights to Pimavanserin |
28-Oct-2010 |
| ACADIA Pharmaceuticals to Present at the Fifth Annual JMP Securities Healthcare Conference on September 28, 2010 |
22-Sep-2010 |
| ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences |
7-Sep-2010 |
| ACADIA Pharmaceuticals Reports Second Quarter 2010 Financial Results |
9-Aug-2010 |
| ACADIA Pharmaceuticals to Announce Second Quarter 2010 Financial
Results on August 9, 2010 |
2-Aug-2010 |
| ACADIA Pharmaceuticals Announces Initiation of New Phase III Trial
with Pimavanserin for Parkinson's Disease Psychosis |
29-Jul-2010 |
| ACADIA Pharmaceuticals To Present at the Ninth Annual Needham
Healthcare Conference on June 9, 2010 |
2-Jun-2010 |
| ACADIA Pharmaceuticals Reports First Quarter 2010 Financial Results |
10-May-2010 |
| ACADIA Pharmaceuticals to Present at the Ninth Annual JMP Securities
Research Conference on May 12, 2010 |
5-May-2010 |
| ACADIA Pharmaceuticals to Announce First Quarter 2010 Financial
Results on May 10, 2010 |
3-May-2010 |
| Dr. Joseph Friedman to Present Data From ACADIA Pharmaceuticals' First Phase III Trial With Pimavanserin for Parkinson's Disease Psychosis at the 62nd American Academy of Neurology Annual Meeting |
14-Apr-2010 |
| ACADIA Pharmaceuticals Reports Financial Results for the Fourth
Quarter and Year Ended December 31, 2009 |
9-Mar-2010 |
| ACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year 2009
Financial Results on March 9, 2010 |
2-Mar-2010 |
| ACADIA Pharmaceuticals to Present at the BIO CEO & Investor
Conference on February 8, 2010 |
1-Feb-2010 |
| ACADIA Pharmaceuticals Reports Third Quarter 2009 Financial Results |
9-Nov-2009 |
| ACADIA Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 9, 2009 |
2-Nov-2009 |
| ACADIA Pharmaceuticals to Present at the BIOCOM Investor Conference on October 26, 2009 |
20-Oct-2009 |
| ACADIA Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference on October 6, 2009 |
6-Oct-2009 |
| ACADIA Pharmaceuticals Provides Update on Pimavanserin Collaborative Development Program |
6-Oct-2009 |
| ACADIA Pharmaceuticals Announces Results from Phase III Trial of Pimavanserin in Parkinson's Disease Psychosis |
1-Sep-2009 |
| ACADIA Pharmaceuticals Reports Second Quarter 2009 Financial Results |
5-Aug-2009 |
| ACADIA Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 5, 2009 |
29-Jul-2009 |
| ACADIA Pharmaceuticals to Present at the Eighth Annual Needham Life Sciences Conference on June 10, 2009 |
3-Jun-2009 |
| ACADIA Pharmaceuticals to Present at the Eighth Annual JMP Securities Research Conference on May 19, 2009 |
13-May-2009 |
| ACADIA Pharmaceuticals Reports First Quarter 2009 Financial Results |
11-May-2009 |
| ACADIA Pharmaceuticals and Biovail Announce Completion of Enrollment in First Pivotal Phase III Trial with Pimavanserin in Patients with Parkinson's Disease Psychosis |
6-May-2009 |
| ACADIA Pharmaceuticals to Announce First Quarter 2009 Financial Results on May 11, 2009 |
5-May-2009 |
| ACADIA Pharmaceuticals and Biovail Form Collaboration to Develop and Commercialize Pimavanserin in North America |
4-May-2009 |
| ACADIA Pharmaceuticals and Meiji Seika Kaisha Form Collaboration to Develop and Commercialize a New Class of Pro-Cognitive Schizophrenia Drugs |
25-Mar-2009 |
| ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2008 |
9-Mar-2009 |
| ACADIA Pharmaceuticals to Present at the Barclays Capital Global Healthcare Conference on March 11, 2009 |
4-Mar-2009 |
| ACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year 2008 Financial Results on March 9, 2009 |
2-Mar-2009 |
| ACADIA Pharmaceuticals to Present at the BIO CEO & Investor Conference on February 10, 2009 |
3-Feb-2009 |
| ACADIA Pharmaceuticals Awarded Grant from The Michael J. Fox Foundation for the Development of Novel ER-beta Agonists for the Treatment of Parkinson's Disease |
7-Jan-2009 |
| ACADIA Pharmaceuticals to Present at The 20th Annual Piper Jaffray Health Care Conference on December 3, 2008 |
25-Nov-2008 |
| ACADIA Pharmaceuticals Reports Third Quarter 2008 Financial Results |
5-Nov-2008 |
| ACADIA Pharmaceuticals to Present at the Rodman & Renshaw 10th Annual Healthcare Conference on November 11, 2008 |
3-Nov-2008 |
| ACADIA Pharmaceuticals to Announce Third Quarter 2008 Financial Results on November 5, 2008 |
29-Oct-2008 |
| ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences |
21-Oct-2008 |
| ACADIA Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference on October 6, 2008 |
29-Sep-2008 |
| ACADIA Pharmaceuticals Files Registration Statement as Required by Previously Announced Committed Equity Financing Facility |
5-Sep-2008 |
| ACADIA Pharmaceuticals to Present at The Thomas Weisel Partners Healthcare Conference on September 4, 2008 |
28-Aug-2008 |
| ACADIA Pharmaceuticals Secures Committed Equity Financing Facility |
5-Aug-2008 |
| ACADIA Pharmaceuticals Announces Second Quarter 2008 Financial Results and Strategic Restructuring |
5-Aug-2008 |
| ACADIA Pharmaceuticals to Announce Second Quarter 2008 Financial Results on August 5, 2008 |
29-Jul-2008 |
| ACADIA Pharmaceuticals Announces Results from ACP-104 Phase IIb Schizophrenia Trial |
16-Jun-2008 |
| ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences |
4-Jun-2008 |
| ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences |
14-May-2008 |
| ACADIA Pharmaceuticals Reports First Quarter 2008 Financial Results |
5-May-2008 |
| ACADIA Pharmaceuticals Announces Election of Laura A. Brege to Board of Directors |
5-May-2008 |
| ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences |
30-Apr-2008 |
| ACADIA Pharmaceuticals to Announce First Quarter 2008 Financial Results on May 5, 2008 |
28-Apr-2008 |
| ACADIA Pharmaceuticals to Present Data from Its Phase II Trial with Pimavanserin for Parkinson's Disease Psychosis at the 60th American Academy of Neurology Annual Meeting |
16-Apr-2008 |
| ACADIA Pharmaceuticals to Present Preclinical Data on ACP-104, ACP-105 and Its Muscarinic Discovery Program at Experimental Biology 2008 Meeting |
4-Apr-2008 |
| ACADIA Pharmaceuticals Initiates Second Phase III Trial with Pimavanserin in Patients with Parkinson's Disease Psychosis |
31-Mar-2008 |
| ACADIA Pharmaceuticals to Present at the 8th Annual Fortis Bank Biotechnology Conference |
28-Mar-2008 |
| ACADIA Pharmaceuticals to Present at Lehman Brothers 11th Annual Global Healthcare Conference |
11-Mar-2008 |
| ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2007 |
5-Mar-2008 |
| ACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year 2007 Financial Results on March 5, 2008 |
27-Feb-2008 |
| ACADIA Pharmaceuticals Appoints John J. Kaiser as Vice President, Strategic Marketing and Commercial Development |
12-Feb-2008 |
| ACADIA Pharmaceuticals Announces Presentation of Data on Pimavanserin Co-Therapy at the 14th Biennial Winter Workshop on Schizophrenia and Bipolar Disorders |
5-Feb-2008 |
| ACADIA Pharmaceuticals to Present at the BIO CEO & Investor Conference on February 12, 2008 |
4-Feb-2008 |
| ACADIA Pharmaceuticals to Present at the 26th Annual JP Morgan Healthcare Conference on January 7, 2008 |
26-Dec-2007 |
| ACADIA Pharmaceuticals Announces Completion of Enrollment of ACP-104 Phase IIb Clinical Trial Ahead of Schedule |
14-Dec-2007 |
| ACADIA Pharmaceuticals to Webcast Its Analyst and Investor Meeting on December 14, 2007 |
6-Dec-2007 |
| ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences |
7-Nov-2007 |
| ACADIA Pharmaceuticals Reports Third Quarter 2007 Financial Results |
5-Nov-2007 |
| ACADIA Pharmaceuticals to Present Preclinical Data on Its Advanced Schizophrenia Programs at the 37th Annual Meeting of the Society for Neuroscience |
2-Nov-2007 |
| ACADIA Pharmaceuticals to Announce Third Quarter 2007 Financial Results on November 5, 2007 |
29-Oct-2007 |
| ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences |
26-Oct-2007 |
| ACADIA Pharmaceuticals to Present at BIO InvestorForum 2007 on October 10, 2007 |
3-Oct-2007 |
| ACADIA Pharmaceuticals Selected to Join New NASDAQ NeuroInsights Neurotech Index |
25-Sep-2007 |
| ACADIA Pharmaceuticals to Present at the 2007 UBS Global Life Sciences Conference |
19-Sep-2007 |
| ACADIA Pharmaceuticals Reports Second Quarter 2007 Financial Results |
6-Aug-2007 |
| ACADIA Pharmaceuticals to Present at the Canaccord Adams 27th Annual Global Growth Conference |
1-Aug-2007 |
| ACADIA Pharmaceuticals to Announce Second Quarter 2007 Financial Results on August 6, 2007 |
30-Jul-2007 |
| ACADIA Pharmaceuticals Earns Milestone on Advancement of Glaucoma Drug Candidate |
16-Jul-2007 |
| ACADIA Pharmaceuticals Initiates Phase IIb Clinical Trial with ACP-104 in Patients with Schizophrenia |
26-Jun-2007 |
| ACADIA Pharmaceuticals Initiates Phase III Trial with Pimavanserin in Patients with Parkinson's Disease Psychosis |
11-Jun-2007 |
| ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences |
24-May-2007 |
| ACADIA Pharmaceuticals Reports First Quarter 2007 Financial Results |
8-May-2007 |
| ACADIA Pharmaceuticals to Announce First Quarter 2007 Financial Results on May 8, 2007 |
1-May-2007 |
| Pimavanserin Approved by USAN as Nonproprietary Name for ACADIA Drug Candidate ACP-103 |
24-Apr-2007 |
| ACADIA Pharmaceuticals Announces Exercise of Over-Allotment by Underwriters |
20-Apr-2007 |
| ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences |
18-Apr-2007 |
| ACADIA Pharmaceuticals Announces Pricing of Public Stock Offering |
4-Apr-2007 |
| ACADIA Pharmaceuticals Announces Proposed Public Stock Offering |
2-Apr-2007 |
| ACADIA Pharmaceuticals' Schizophrenia Programs to Be Presented at the 2007 International Congress on Schizophrenia Research |
29-Mar-2007 |
| ACADIA Announces Positive Results From ACP-103 Phase II Schizophrenia Co-Therapy Trial |
19-Mar-2007 |
| ACADIA Pharmaceuticals to Present at Lehman Brothers 10th Annual Global Healthcare Conference |
14-Mar-2007 |
| ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2006 |
6-Mar-2007 |
| ACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year 2006 Financial Results on March 6, 2007 |
27-Feb-2007 |
| ACADIA Pharmaceuticals to Present at the BIO CEO & Investor Conference on February 13, 2007 |
6-Feb-2007 |
| ACADIA Pharmaceuticals to Present at the 25th Annual JP Morgan Healthcare Conference on January 11, 2007 |
3-Jan-2007 |
| ACADIA Pharmaceuticals Adds Complementary Intellectual Property for Serotonin Platform |
4-Dec-2006 |
| ACADIA Pharmaceuticals Reports Third Quarter 2006 Financial Results |
6-Nov-2006 |
| ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences |
1-Nov-2006 |
| ACADIA Pharmaceuticals to Announce Third Quarter 2006 Financial Results on November 6, 2006 |
30-Oct-2006 |
| ACADIA Pharmaceuticals to Support Launch of New Company Focused on Substance Abuse Therapeutics |
23-Oct-2006 |
| ACADIA Pharmaceuticals to Present at BIO InvestorForum 2006 on October 18, 2006 |
11-Oct-2006 |
| ACADIA Pharmaceuticals Announces Accelerated Timing of ACP-103 Phase II Trial in Patients with Schizophrenia; Top-Line Results for Complete 400-Patient Study Expected in Q1 2007 |
25-Sep-2006 |
| ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences |
12-Sep-2006 |
| ACADIA Pharmaceuticals Reports Second Quarter 2006 Financial Results |
8-Aug-2006 |
| ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences |
3-Aug-2006 |
| ACADIA Pharmaceuticals to Announce Second Quarter 2006 Financial Results on August 8, 2006; ACADIA to Host Conference Call and Webcast on Tuesday, August 8, 2006, at 5:00 p.m. Eastern Time |
2-Aug-2006 |
| ACADIA Pharmaceuticals Announces Encouraging Results from Initial Clinical Trials with ACP-104 in Patients with Schizophrenia |
13-Jul-2006 |
| ACADIA Pharmaceuticals to Present at the Jefferies Life Sciences Conference on June 27, 2006 |
20-Jun-2006 |
| ACADIA Pharmaceuticals to Present at Needham's Fifth Annual Biotechnology and Medical Technology Conference |
8-Jun-2006 |
| ACADIA Pharmaceuticals Announces Appointment of Roger G. Mills, M.D., as Executive Vice President, Development |
5-Jun-2006 |
| ACADIA Pharmaceuticals Added to NASDAQ Biotech Index |
15-May-2006 |
| ACADIA Pharmaceuticals Reports First Quarter 2006 Financial Results |
10-May-2006 |
| ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences |
8-May-2006 |
| ACADIA Pharmaceuticals to Announce First Quarter 2006 Financial Results on May 10, 2006 |
3-May-2006 |
| ACADIA Pharmaceuticals Announces Pricing of Public Stock Offering |
27-Apr-2006 |
| ACADIA Pharmaceuticals Announces Proposed Public Stock Offering |
24-Apr-2006 |
| ACADIA Pharmaceuticals Announces Positive Clinical Trial Results Demonstrating That ACP-103 Increases Slow Wave Sleep |
19-Apr-2006 |
| ACADIA Pharmaceuticals Announces Positive Results From Phase II Trial of ACP-103 for Treatment-Induced Psychosis in Patients With Parkinson's Disease |
23-Mar-2006 |
| ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences |
2-Mar-2006 |
| ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2005 |
1-Mar-2006 |
| ACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year 2005 Results on March 1, 2006 |
22-Feb-2006 |
| ACADIA Pharmaceuticals Announces Advancements in Two Preclinical Programs |
21-Feb-2006 |
| ACADIA Pharmaceuticals to Present at the BIO CEO & Investor Conference 2006 on February 14, 2006 |
7-Feb-2006 |
| ACADIA Pharmaceuticals Announces Additional $10 Million Equity Investment by Sepracor |
17-Jan-2006 |
| ACADIA Pharmaceuticals Announces Appointment of David C. Furlano, Ph.D., as Vice President, Regulatory Affairs |
9-Jan-2006 |
| ACADIA Pharmaceuticals Discovers Novel Isoform-Selective Retinoic Acid Receptor Agonists |
15-Dec-2005 |
| ACADIA Pharmaceuticals Reports Results From Phase II Study of ACP-103 in Schizophrenia Patients With Haloperidol-Induced Akathisia |
1-Dec-2005 |
| Acadia Pharmaceuticals Reports Third Quarter 2005 Financial Results |
10-Nov-2005 |
| ACADIA Pharmaceuticals Announces Initial Results From Ongoing Single-Dose Clinical Trial of ACP-104 in Schizophrenia Patients |
10-Nov-2005 |
| ACADIA Pharmaceuticals to Announce Third Quarter 2005 Financial Results on November 10, 2005 |
3-Nov-2005 |
| ACADIA Pharmaceuticals to Present at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference on November 8, 2005 |
1-Nov-2005 |
| ACADIA Pharmaceuticals to Present at BIO InvestorForum 2005 on October 20, 2005 |
13-Oct-2005 |
| ACADIA Pharmaceuticals Earns Milestone on Advancement of Neuropathic Pain Clinical Program |
3-Oct-2005 |
| ACADIA Pharmaceuticals Study Identifies Molecular Properties of ACP-104 That Predict Unique Antipsychotic Activity |
22-Sep-2005 |
| ACADIA Pharmaceuticals to Present at the 2005 UBS Global Life Sciences Conference on September 27, 2005 |
20-Sep-2005 |
| ACADIA Pharmaceuticals Officially Opens New Chemistry R&D Facility in Sweden |
16-Sep-2005 |
| ACADIA Pharmaceuticals Announces Election of Michael T. Borer to Board of Directors |
13-Sep-2005 |
| ACADIA Pharmaceuticals Comments on Civil Litigation |
24-Aug-2005 |
| ACADIA Pharmaceuticals to Present at the 8th Annual San Diego Growth Conference on August 19, 2005 |
17-Aug-2005 |
| ACADIA Pharmaceuticals Reports Second Quarter 2005 Financial Results |
10-Aug-2005 |
| ACADIA Pharmaceuticals to Announce Second Quarter 2005 Financial Results on August 10, 2005 |
3-Aug-2005 |
| ACADIA Pharmaceuticals to Present at the 25th Annual Adams Harkness Summer Seminar on August 3, 2005 |
27-Jul-2005 |
| ACADIA Pharmaceuticals Announces Encouraging Interim Results From Ongoing Phase II Trial of ACP-103 for Treatment-Induced Psychosis in Patients With Parkinson's Disease |
22-Jun-2005 |
| ACADIA Pharmaceuticals to Present at the Fourth Annual Needham Biotechnology Conference |
19-May-2005 |
| ACADIA Pharmaceuticals Expands Technology Platform to Target Tyrosine Kinase Linked Receptors |
17-May-2005 |
| ACADIA Pharmaceuticals Reports First Quarter 2005 Financial Results |
11-May-2005 |
| ACADIA Pharmaceuticals to Present at Banc of America Securities Health Care Conference 2005 |
10-May-2005 |
| ACADIA Pharmaceuticals to Announce First Quarter 2005 Financial Results on May 11, 2005 |
4-May-2005 |
| ACADIA Pharmaceuticals Announces Election of Mary Ann Gray, Ph.D. to Board of Directors |
28-Apr-2005 |
| ACADIA Pharmaceuticals Announces $36 Million Financing |
15-Apr-2005 |
| ACADIA Pharmaceuticals to Present at the Future Leaders in the Biotech Industry Conference on April 7, 2005 |
31-Mar-2005 |
| ACADIA Announces Management Appointments in Business Development and Research and Development |
7-Mar-2005 |
| ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2004 |
3-Mar-2005 |
| ACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year 2004 Financial Results on March 3, 2005 |
24-Feb-2005 |
| ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences |
22-Feb-2005 |
| ACADIA Pharmaceuticals to Present at the BIO CEO & Investor Conference on February 24, 2005 |
17-Feb-2005 |
| ACADIA Pharmaceuticals to Present at the Piper Jaffray 17th Annual Health Care Conference on January 26, 2005 |
19-Jan-2005 |
| ACADIA Pharmaceuticals Announces Partnership With Sepracor |
11-Jan-2005 |
| ACADIA Pharmaceuticals Reports Third Quarter 2004 Financial Results |
10-Nov-2004 |
| ACADIA Pharmaceuticals Inc. Third Quarter 2004 Earnings Conference Call |
4-Nov-2004 |
| ACADIA Pharmaceuticals to Announce Third Quarter 2004 Financial Results on November 10, 2004 |
3-Nov-2004 |
| ACADIA Pharmaceuticals Earns Milestone on Advancement of Neuropathic Pain Drug |
26-Oct-2004 |
| ACADIA Pharmaceuticals to Present at the Rodman & Renshaw Techvest 6th Annual Healthcare Conference on October 26, 2004 |
19-Oct-2004 |
| ACADIA Pharmaceuticals to Present at the Bio Emerging Company Investor Forum |
7-Oct-2004 |
| ACADIA Clinical Study Shows ACP-103 Improves Clinical Profile of Antipsychotic Drug Treatment |
15-Sep-2004 |
| ACADIA Pharmaceuticals to Expand Scandinavian Chemistry Operations |
2-Sep-2004 |
| ACADIA Pharmaceuticals Reports Second Quarter 2004 Financial Results |
11-Aug-2004 |
| ACADIA Pharmaceuticals to Announce Second Quarter 2004 Financial Results on August 11, 2004 |
5-Aug-2004 |
| ACADIA Pharmaceuticals Inc. Second Quarter 2004 Earnings Conference Call |
5-Aug-2004 |
| ACADIA Study Links ACP-104 (N-desmethylclozapine) to Improved Cognition in Schizophrenia Patients |
3-Aug-2004 |
| ACADIA Pharmaceuticals to Present at the 24th Annual Adams Harkness Summer Seminar on August 5, 2004 |
30-Jul-2004 |
| ACADIA Pharmaceuticals Presents Favorable Results From Phase Ib/IIa Clinical Trial and PET Study of ACP-103 |
29-Jun-2004 |
| ACADIA Pharmaceuticals Announces Initial Public Offering |
26-May-2004 |
| ACADIA Pharmaceuticals Achieves Milestone as Allergan Advances Glaucoma Drug Candidate |
8-Jan-2004 |
| ACADIA Pharmaceuticals Successfully Completes Phase I Clinical Testing of ACP-103 |
6-Aug-2003 |
| ACADIA Pharmaceuticals Expands Private Placement to $28 Million |
12-Jun-2003 |
| Allergan and ACADIA Pharmaceuticals Announce New Drug Discovery and Development Collaboration |
15-Apr-2003 |
| ACADIA Pharmaceuticals Completes $25 Million Private Placement |
28-Mar-2003 |
| ACADIA Initiates Clinical Trials for ACP-103 - Initially Targets Treatment-Induced Dysfunction in Parkinson's Disease |
22-Jan-2003 |
| ACADIA Expands Pain Portfolio to Include New GPCR Targets |
10-Dec-2002 |
| Paul S. Anderson, Ph.D., Appointed To ACADIA Pharmaceutical's Scientific Advisory Board |
13-Nov-2002 |
| ACADIA Discovers Novel Small Molecule Leads for the V2 Vasopressin Receptor |
26-Sep-2002 |
| ACADIA Applies Chemical Genomics to Discover Small Molecule Leads for Numerous GPCRs and Nuclear Rececptors |
13-Jun-2002 |
| ACADIA Announces Chemical-Genomics Collaboration with Amgen to Discover Small Molecule Drugs |
3-Jan-2002 |
 |
